Medicare Enrolled

Dr. Fiaz Zaman, M.D.

Optician · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2855 GRAMERCY ST, Houston, TX 77025
7136686828
In practice since 2005 (20 years)
NPI: 1073508164 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zaman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zaman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zaman

Dr. Fiaz Zaman is an optician specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zaman performed 3,365 Medicare services across 2,946 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zaman received a total of $151,215 from 34 pharmaceutical and/or device companies across 601 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zaman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 19% volume in TX $151,215 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,365
Medicare services
Top 19% in TX for optician
2,946
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~168 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 767 $86 $384
Optic nerve imaging (OCT scan) 586 $26 $276
Comprehensive eye exam, established patient 513 $86 $380
Visual field test, extended 469 $44 $502
Eye exam, established patient, focused 258 $57 $263
Office visit, established patient (20-29 min) 168 $68 $271
Corneal topography and eye depth measurement 139 $35 $434
Cataract surgery with lens implant 129 $411 $5,663
New patient office visit (45-59 min) 76 $105 $493
Exam of the internal drainage system of eye 65 $21 $153
Ultrasound scan of cornea to determine thickness 57 $7 $87
Comprehensive eye exam, new patient 57 $96 $454
Removal of recurring cataract in lens capsule using a laser 30 $245 $2,475
Retinal imaging (OCT scan) 26 $27 $276
Office visit, established patient (10-19 min) 25 $44 $166
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.8% high complexity
19.9% medium
76.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$151,215
Total received (2018-2024)
Avg $21,602/year across 7 years
Top 3% in TX for optician
34
Companies
601
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,222 (59.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$53,074 (35.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,919 (5.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,602
2023
$1,488
2022
$2,064
2021
$10,836
2020
$35,340
2019
$56,110
2018
$37,775

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Aerie Pharmaceuticals, Inc.
$66,994
Allergan Inc.
$49,917
Allergan, Inc.
$17,241
ABBVIE INC.
$7,210
NEW WORLD MEDICAL,INC.
$2,005
Alcon Vision LLC
$1,499
Ivantis, Inc
$839
Glaukos Corporation
$789
Bausch & Lomb, a division of Bausch Health US, LLC
$623
AbbVie Inc.
$506
GLAUKOS CORPORATION
$473
Novartis Pharmaceuticals Corporation
$435
Sun Pharmaceutical Industries Inc.
$394
Carl Zeiss Meditec, Inc.
$277
Kala Pharmaceuticals, Inc.
$261
Carl Zeiss Meditec USA, Inc.
$231
Bausch & Lomb Americas Inc.
$228
SUN PHARMACEUTICAL INDUSTRIES INC.
$157
Johnson & Johnson Surgical Vision, Inc.
$152
RxSight Inc
$150
Tarsus Pharmaceuticals, Inc.
$144
Oyster Point Pharma, Inc.
$106
Ocular Therapeutix, Inc.
$89
Eyevance Pharmaceuticals LLC
$85
Vanda Pharmaceuticals Inc.
$80
Iridex Corporation
$59
Harrow Eye, LLC
$53
Shire North American Group Inc
$46
Sight Sciences, Inc.
$45
Thea Pharma Inc.
$36
Dompe US, Inc.
$29
Akorn, Inc.
$23
EYEVANCE PHARMACEUTICALS LLC
$21
TissueTech, Inc.
$15
Top 3 companies account for 88.7% of total payments
Associated products mentioned in payments ›
ALPHAGAN P · ARGOS · AcrySof IQ PanOptix · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · CIRRUS HD-OCT · CLARUS 500 · COMBIGAN · Catalys Laser System · Cequa · Clareon · DEXTENZA · DURYSTA · FF450plus · FORUM · Flarex · HETLIOZ · HYDRUS Microstent · Hetlioz · Humphrey HFA · Hydrus · Hydrus Microstent · INVELTYS · IOLMaster 500 · ISTENT INJECT W · IYUZEH · KXL SYSTEM · KXL System · LOTEMAX GEL · LOTEMAX SM · LUMERA 700 · LUMIGAN · MIEBO · OMNI SURGICAL SYSTEM · OXERVATE · PROLENSA · PanOptix · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · REVOLVE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · Radius · ReSTOR · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · TYRVAYA · TearCare SmartLid · Tecnis Multifocal Family of 1-piece IOLS · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · Zioptan · iDose · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in TX.

Equivalent to $4,494 per 100 Medicare services performed
Looking for an optician specialist in Houston?
Compare opticians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
512
Per 100K population
10.8
County median income
$73,104
Nearest hospital
WOMANS HOSPITAL OF TEXAS,THE
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Zaman is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Zaman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zaman performed 767 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zaman receive payments from pharmaceutical companies?
Yes. Dr. Zaman received a total of $151,215 from 34 companies across 601 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zaman's costs compare to other opticians in Houston?
Dr. Zaman's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zaman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →